S095035

· Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S095035, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP [Phase 1, Phase 2]

See pricing